Loading clinical trials...
Loading clinical trials...
This project will test the hypotheses that people with 5-HT RBD have systemic alpha- synuclein pathology, prodromal DLB signs, and brainstem lesions in regions that control REM sleep. AIM 1 will seek ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Minnesota
NCT06553625 · Parkinson Disease, Dystonia, and more
NCT07410598 · Parkinson Disease, Deep Brain Stimulation
NCT05471960 · REM Sleep Behavior Disorder
NCT07187843 · Parkinson Disease, Parkinsonian Disorders, and more
NCT07545473 · Dementia, Neurodegenerative Diseases, and more
University of Minnesota
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions